GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Total Assets

Abaxis (Abaxis) Total Assets : $341.1 Mil (As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Total Assets?

Abaxis's Total Assets for the quarter that ended in Mar. 2018 was $341.1 Mil.

Total Assets is connected with ROA %. Abaxis's annualized ROA % for the quarter that ended in Mar. 2018 was 11.79%. Total Assets is also linked to Revenue through Asset Turnover. Abaxis's Asset Turnover for the quarter that ended in Mar. 2018 was 0.20.


Abaxis Total Assets Historical Data

The historical data trend for Abaxis's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Total Assets Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 217.38 269.06 271.38 305.65 341.10

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 305.65 317.24 319.95 338.76 341.10

Abaxis Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Abaxis's Total Assets for the fiscal year that ended in Mar. 2018 is calculated as

Total Assets=Total Equity (A: Mar. 2018 )+Total Liabilities (A: Mar. 2018 )
=290.693+50.41
=341.1

Abaxis's Total Assets for the quarter that ended in Mar. 2018 is calculated as

Total Assets=Total Equity (Q: Mar. 2018 )+Total Liabilities (Q: Mar. 2018 )
=290.693+50.41
=341.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abaxis  (NAS:ABAX) Total Assets Explanation

Total Assets is connected with ROA %.

Abaxis's annualized ROA % for the quarter that ended in Mar. 2018 is

ROA %=Net Income (Q: Mar. 2018 )/( (Total Assets (Q: Dec. 2017 )+Total Assets (Q: Mar. 2018 ))/ count )
=40.08/( (338.763+341.103)/ 2 )
=40.08/339.933
=11.79 %

Note: The Net Income data used here is four times the quarterly (Mar. 2018) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Abaxis's Asset Turnover for the quarter that ended in Mar. 2018 is

Asset Turnover
=Revenue (Q: Mar. 2018 )/( (Total Assets (Q: Dec. 2017 )+Total Assets (Q: Mar. 2018 ))/ count )
=67.918/( (338.763+341.103)/ 2 )
=67.918/339.933
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Abaxis Total Assets Related Terms

Thank you for viewing the detailed overview of Abaxis's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020